Senior Director, Medical Affairs

Mineralys Therapeutics is a clinical-stage biopharmaceutical company headquartered in Radnor, Pennsylvania, dedicated to developing targeted therapies for cardio-renal-metabolic conditions driven by dysregulated aldosterone. The company is focused on addressing diseases such as hypertension, chronic kidney disease (CKD), and obstructive sleep apnea (OSA). Their lead product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. The Senior Director, Medical Affairs will play a pivotal role in shaping and executing the global medical affairs strategy to support the company's pipeline and future commercial products.